Targeting translation initiation as novel therapeutic in CLL

Anne Largeot; Jerome Paggetti; Etienne Moussay

Targeting translation initiation as novel therapeutic in CLL

Tumor Stroma Interactions

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S16-S17
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	64
Publication status	Published - 23 Dec 2023

Cite this

@article{4fc32a0e73644403a687a5291047c87f,

title = "Targeting translation initiation as novel therapeutic in CLL",

author = "Anne Largeot and Jerome Paggetti and Etienne Moussay",

year = "2023",

month = dec,

day = "23",

language = "English",

volume = "64",

pages = "S16--S17",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Targeting translation initiation as novel therapeutic in CLL

AU - Largeot, Anne

AU - Paggetti, Jerome

AU - Moussay, Etienne

PY - 2023/12/23

Y1 - 2023/12/23

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_wos-starter-api-2022&SrcAuth=WosAPI&KeyUT=WOS:001090883600016&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1042-8194

VL - 64

SP - S16-S17

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

ER -

Targeting translation initiation as novel therapeutic in CLL

Other files and links

Cite this